Xyl01 0002 01
Chemical structure of lidocaine hydrochloride shown as a molecular diagram displaying its chemical bonds and atomic groups.*
Xylocaine Injection, Solution
Product Images NDC 63323-489
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 63323-489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Xyl01 0002 02
Chemical structure diagram showing the molecular formula of the active ingredient Lidocaine Hydrochloride with Epinephrine Bitartrate.*
Xyl01 0002 03
Xyl01 0002 04
Label for Xylocaine 0.5% lidocaine HCl injection solution, USP, 250 mg/50 mL (5 mg/mL) in a 50 mL multiple dose vial. Indicated for infiltration and nerve block, not for caudal or epidural use. Contains storage and usage instructions. Labeler is Fresenius Kabi USA, LLC.*
Xyl01 0002 05
Xylocaine 0.5% (5 mg/mL) injection, solution in 250 mg/50 mL vials. Label indicates use for infiltration and nerve block, not for caudal or epidural use. Contains Lidocaine HCl 5 mg, sodium chloride 8 mg, methylparaben 1 mg per mL. Pack of 25 multiple dose vials by Fresenius Kabi USA, LLC. Storage instructions and caution notes included.*
Xyl01 0002 06
Xylocaine 1% lidocaine HCl injection solution in a 20 mL multiple dose vial. The label specifies 200 mg per 20 mL (10 mg per mL) strength, indicated for infiltration and nerve block use, not for caudal or epidural use. Manufactured by Fresenius Kabi USA, LLC with storage instructions and sterility information included.*
Xyl01 0002 07
Xylocaine 1% (lidocaine HCl injection, USP) solution for injection with a concentration of 200 mg per 20 mL (10 mg per mL) in a label for multiple dose vials. Indicated for infiltration and nerve block, not for caudal or epidural use. Label includes ingredient amounts per mL, storage instructions, and manufacturer Fresenius Kabi USA, LLC.*
Xyl01 0002 08
Label for Xylocaine-MPF injection, a 1% lidocaine hydrochloride and epinephrine solution (1:200,000) for infiltration and nerve block, including caudal and epidural use. The label notes methylparaben-free, a 30 mL single dose vial, and storage instructions from Fresenius Kabi USA, LLC.*
Xyl01 0002 09
Xylocaine-MPF injection solution with lidocaine HCl 10 mg/mL and epinephrine bitartrate 0.005 mg/mL, packaged as 25 single dose 30 mL vials. Label indicates use for infiltration and nerve block including caudal and epidural use, methylparaben free, sterile and nonpyrogenic, by Fresenius Kabi USA, LLC.*
Xyl01 0002 10
Label for Xylocaine-MPF 1.5% injection solution containing lidocaine HCl and epinephrine 1:200,000. The vial is 30 mL single dose with 450 mg lidocaine per 30 mL (15 mg/mL). Indicated for infiltration and nerve block including caudal and epidural use. Methylparaben free and labeled for Rx only. Manufactured by Fresenius Kabi USA, LLC.*
Xyl01 0002 11
Xylocaine-MPF injection, USP (lidocaine HCl and epinephrine) with epinephrine 1:200,000, 1.5% strength, 450 mg per 30 mL (15 mg/mL). The label indicates 25 single dose vials of 30 mL for infiltration and nerve block including caudal and epidural use. It is methylparaben free and sterile, nonpyrogenic, manufactured by Fresenius Kabi USA, LLC.*
Xyl01 0002 12
Xylocaine 2% (lidocaine HCl and epinephrine injection, USP) 400 mg per 20 mL (20 mg per mL) solution for infiltration and nerve block, not for caudal or epidural use, in a 20 mL multiple dose vial. Label indicates it contains epinephrine at 1:100,000 concentration. Manufactured by Fresenius Kabi USA, LLC, with storage and usage instructions including protection from light and temperature requirements.*
Xyl01 0002 13
Xylocaine 2% injection solution label containing lidocaine hydrochloride 20 mg/mL and epinephrine bitartrate 0.01 mg/mL. The label indicates it is for infiltration and nerve block, not for caudal or epidural use. Packaging includes 25 multiple dose vials of 20 mL each, manufactured by Fresenius Kabi USA, LLC. Additional ingredients and storage instructions are also displayed.*
Xyl01 0002 14
Xylocaine 2% (lidocaine HCl Injection, USP) solution label showing 200 mg per 10 mL (20 mg per mL) strength. It is indicated for infiltration and nerve block, not for caudal or epidural use. The vial is 10 mL multiple dose, labeled by Fresenius Kabi USA, LLC with storage and sterility information.*
Xyl01 0002 15
Label for Xylocaine (lidocaine HCl injection, USP) 2% solution, 200 mg per 10 mL (20 mg/mL) strength. Indicated for infiltration and nerve block, not for caudal or epidural use. Pack includes 25 multiple dose vials of 10 mL each. Manufactured by Fresenius Kabi USA, LLC. Label displays active ingredients, storage instructions, and handling information.*
Xyl01 0002 16
Xylocaine-MPF injection solution label indicating 2% strength with epinephrine 1:200,000, 400 mg per 20 mL (20 mg per mL) in a 20 mL single dose vial. The label states the product is for infiltration and nerve block, including caudal and epidural use, and is methylparaben free. Manufactured by Fresenius Kabi USA, with storage instructions and warnings about light protection and color changes.*
Xyl01 0002 17
Xylocaine-MPF 2% injection solution with epinephrine 1:200,000, containing 400 mg lidocaine HCl per 20 mL vial (20 mg/mL). Label indicates single dose vials, 20 mL each, for infiltration and nerve block, including caudal and epidural use. The product is sterile, methylparaben free, labeled by Fresenius Kabi USA, LLC.*
Xyl01 0002 18
Label for Xylocaine-MPF (lidocaine HCl Injection, USP) 0.5% solution, 250 mg per 50 mL (5 mg per mL). The 50 mL single-dose vial is for infiltration and intravenous regional anesthesia. Methylparaben free. Manufactured by Fresenius Kabi USA, LLC. Storage instructions and safety warnings, including single-dose vial discard policy, are also visible.*
Xyl01 0002 19
Xylocaine-MPF Lidocaine HCl Injection USP 0.5% (5 mg/mL) in 25 single dose vials of 50 mL each. Label indicates use for infiltration and intravenous regional anesthesia. Methylparaben free, store at controlled room temperature. Manufactured by Fresenius Kabi USA, LLC.*
Xyl01 0002 20
Label for Xylocaine-MPF 1% lidocaine HCl injection, USP, 50 mg per 5 mL (10 mg per mL) in a 5 mL single dose vial. The label states it is for infiltration and nerve block including caudal and epidural use, methylparaben free, sterile and nonpyrogenic. Manufacturer is Fresenius Kabi USA, with storage instructions at 20° to 25°C.*
Xyl01 0002 21
Label for Xylocaine-MPF (lidocaine HCl injection, USP) 1% injection solution providing 50 mg per 5 mL (10 mg per mL). It is indicated for infiltration and nerve block including caudal and epidural use. The label shows a pack size of 25 single dose vials, each vial containing 5 mL. The product is methylparaben free and intended for prescription use, supplied by Fresenius Kabi USA, LLC.*
Xyl01 0002 22
Label for Xylocaine - MPF (lidocaine HCl Injection, USP) 2% solution, 40 mg per 2 mL (20 mg per mL) in a 2 mL single dose vial. The label indicates use for infiltration and nerve block including caudal and epidural procedures. Manufactured by Fresenius Kabi USA, Lake Zurich, IL, and states methylparaben free.*
Xyl01 0002 23
Label for Xylocaine-MPF lidocaine HCl Injection, USP 2% (20 mg/mL) solution. The label indicates 40 mg per 2 mL in a pack of 25 single dose vials. Intended for infiltration and nerve block including caudal and epidural use. Methylparaben free. Labeler is Fresenius Kabi USA, LLC.*
Xyl01 0002 24
Label for Xylocaine-MPF 2% (lidocaine HCl injection, USP) solution. The vial contains 5 mL of 100 mg per 5 mL (20 mg per mL) lidocaine. Intended for infiltration and nerve block, including caudal and epidural use. It is methylparaben free, sterile, and nonpyrogenic. Manufactured by Fresenius Kabi USA, LLC.*
Xyl01 0002 25
Xylocaine-MPF (lidocaine HCl Injection, USP) 2% solution, 20 mg/mL strength, in 5 mL single-dose vials. The label indicates use for infiltration and nerve block, including caudal and epidural use. It is methylparaben free, sterile, nonpyrogenic, and contains lidocaine HCl 20 mg, sodium chloride 6 mg, and pH adjusted to approximately 6.5 per mL. Manufactured by Fresenius Kabi USA, LLC, with storage instructions and single-dose vial usage noted.*
Xyl01 0002 26
Xylocaine 0.5% injection solution containing lidocaine HCl and epinephrine 1:200,000. The label states 250 mg per 50 mL (5 mg per mL) in a 50 mL multiple dose vial. It is indicated for infiltration and nerve block, not for caudal or epidural use. The product is from Fresenius Kabi USA, LLC, with storage and handling instructions included.*
Xyl01 0002 27
Xylocaine injection label with lidocaine HCl 5 mg/mL and epinephrine 0.005 mg/mL (1:200,000). The 50 mL vial contains 25 multiple doses at 0.5% strength, indicated for infiltration and nerve block, not for caudal or epidural use. Label shows storage instructions, contents, and is provided by Fresenius Kabi USA, LLC.*
Xyl01 0002 28
Xylocaine (lidocaine HCl and epinephrine injection, USP) 1% solution with epinephrine 1:100,000, 100 mg per 10 mL (10 mg per mL) in a 10 mL multiple dose vial. Intended for infiltration and nerve block, not for caudal or epidural use. Labeler: Fresenius Kabi USA, LLC. The label includes handling instructions such as protection from light and storage conditions, along with warnings about discoloration and precipitate presence.*
Xyl01 0002 29
Xylocaine 1% injection label with lidocaine hydrochloride 10 mg/mL and epinephrine bitartrate 0.01 mg/mL. The solution is for infiltration and nerve block, not for caudal or epidural use. The package contains 25 multiple dose vials of 10 mL each. Labeler is Fresenius Kabi USA, LLC, with storage and handling instructions included.*
Xyl01 0002 30
Label for Xylocaine-MPF (lidocaine HCl injection, USP) 1% solution, 20 mg per 2 mL (10 mg per mL) in a 2 mL single dose vial. Intended for infiltration and nerve block including caudal and epidural use. The label also notes the product is methylene/paraben free, manufactured by Fresenius Kabi USA, LLC in Lake Zurich, IL.*
Xyl01 0002 31
Label for Xylocaine-MPF (lidocaine HCl injection, USP) 1% solution, providing 20 mg per 2 mL (10 mg per mL) strength. The product is for infiltration and nerve block, including caudal and epidural use, and is methylparaben free. The package contains 25 single-dose 2 mL vials. Manufactured by Fresenius Kabi USA, LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
